Sima and John thought they had found their dream home. It had everything they were looking for — and one feature they didn’t expect. Must Read. Thanks to Jeff Bezos, you can n ...
New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell ...